Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease. J of Skin [Internet]. 2020 May 8 [cited 2025 Apr. 18];4(3):256-9. Available from: https://skin.dermsquared.com/skin/article/view/651